Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0463-2026

Precision CRF; Recall

Precision CRF; Model Number: 706400;

FDA recall Class II

Ongoing

FDA lists this Class II recall for Precision CRF;. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0463-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Oct 1, 2025
FDA report date
Nov 19, 2025
Quantity in commerce
42 units
Distribution
See key details
FDA cause
Device Design

What is being recalled?

Precision CRF; Model Number: 706400;

Affected model & UDI checker

Search the exact identifiers published for Z-0463-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
706400Precision CRF;Check source noticeNot specified
Not specifiedPrecision CRF;Check source notice00884838110588
FDA code information

Model Number: 706400; UDI-DI: 00884838110588; Serial Number: 19, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 10001178, 10001179, 10001181, 10001182, 10001184, 10001185, 10001186, 10001187, 10001188, 10001189, 10001190, 10001191, 10001192, 10001193, 10001194, 10001195, 10001196, 10001197, 10001199, 10001200, 10001201, 10001202, 10001203, 10001204, 10001205, 10001206, 10001208, 10001209;

View the original FDA recall notice

Why was this product recalled?

Philips has identified that some ceiling suspension telescopic carriages manufactured from July 2024 through June 2025 may be difficult to move vertically (i.e. additional force/physical exertion required for manual movement) due to potential manufacturing issues.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Philips Medical Systems DMC GmbH take?

On October 1, 2025, "URGENT MEDICAL DEVICE CORRECTION" letters dated September 30, 2025, were sent to customers. The letters described the problem, product and actions to be taken. Actions to be taken: It is safe to continue to use the system(s) in accordance with the intended use. It is recommended that customers use the motorized movement option until the technical solution has been implemented. The system may experience motor drive errors if the force for movement exceeds 110N, which restricts the motorized movement. If the motorized movement does not function, customers should contact their local service representative. B. Circulate this notice to all users of this device so that they are aware of the issue and associated hazard/harm. C. Please retain this Urgent Medical Device Correction letter with your system(s) until the solution is installed; ensure the notice is in a place likely to be seen/viewed. 5. Actions planned by Philips to correct the problem. Philips will provide the technical solution details when finalized. This notice has been reported to the appropriate Regulatory Agencies. If you need any further information or support concerning this issue, please contact your local Philips representative. For North America, contact the Customer Care Solutions Center (1-800-722-9377, 8AM 8PM EST, Monday-Friday).

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology